Compounds of the formula I ##STR00001## in which X, Y, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings indicated in claim 1, are inhibitors of CHK1 CHK2 and SGK kinases and can be employed, inter alia, for the treatment of cancer.

 
Web www.patentalert.com

< Methods for the directed expansion of epitopes for use as antibody ligands

> Quinoline Derivatives and Their Use as 5-HT6 Ligands
~ 00497